Claudia Pfohler-Hamsch

Homburg, SL, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.

Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 18, 2025

Early versus late response to PD-1-based immunotherapy in metastatic melanoma.

Early versus late response to PD-1-based immunotherapy in metastatic melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 05, 2024

Cutaneous adverse events to systemic anticancer therapies : Hand-foot syndrome and nail changes

Cutaneous adverse events to systemic anticancer therapies : Hand-foot syndrome and nail changes

Journal: Dermatologie (Heidelberg, Germany)

Published: April 10, 2024

The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects.

The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 10, 2023

Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM.

Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM.

Journal: EBioMedicine

Published: March 31, 2023

Characterisation and outcome of RAC1 mutated melanoma.

Characterisation and outcome of RAC1 mutated melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 23, 2022

Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.

Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 28, 2021

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 28, 2020

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma.

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 31, 2017

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity.

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 30, 2016

A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes.

A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes.

Journal: Dermatology and therapy

Published: July 21, 2016

Contact allergic gastritis : Rare manifestation of a metal allergy

Contact allergic gastritis : Rare manifestation of a metal allergy

Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete

Published: February 25, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026